PD-L1 localization correlated well with tumor levels of CCX559: at 1 and 5 days post dosing when CCX559 is present in tumors, PD-L1 is intracellular; at 12 days when CCX559 has been cleared from tumors, cell surface PD-L1 is detected again. This evidence concerns the gene CD274 and neoplasm.